Skip To Main Content

This website is intended exclusively for healthcare professionals residing and/or working in the UAE.

Science at Sanofi

Discover a wide variety of articles, videos, podcasts, accredited courses, applications, conferences and scientific events in different therapeutic areas

Learn more about these therapeutic areas

Atopic Dermatitis

Eosinophilic Esophagitis

Multiple Sclerosis

Acquired Thrombotic Thrombocytopenic Purpura (ATTP)

Acquired Thrombotic Thrombocytopenic Purpura (ATTP)

Prurigo Nodularis

Science

We offer you a 360º view of relevant and trustworthy content in our therapeutic areas

EPOS2020/EUFOREA Expert Opinion on Defining Disease States and Therapeutic Goals in CRSwNP

EPOS2020/EUFOREA Expert Opinion on Defining Disease States and Therapeutic Goals in CRSwNP

EoE Pathophysiology

EoE Pathophysiology

VESTIGE Trial Results: Dupilumab in Type 2 Asthma

cutting-edge-science

VESTIGE Trial Results: Dupilumab in Type 2 Asthma

This video presents results from the Phase 4 VESTIGE trial, demonstrating how dupilumab improves airway structure and function in severe type 2 asthma. Using breakthrough Functional Respiratory Imaging technology, the study reveals structural improvements that conventional lung function tests may not detect.

New horizon of RSV lower respiratory tract disease LRTD in infants: Reflection on two seasons of prevention

New horizon of RSV lower respiratory tract disease LRTD in infants: Reflection on two seasons of prevention

Considerations for bullous pemphigoid management

Considerations for bullous pemphigoid management

The management of bullous pemphigoid is challenging and new treatment approaches are needed. Read this article to find out more.

Treatments and challenges for bullous pemphigoid

Treatments and challenges for bullous pemphigoid

Systemic corticosteroids and other immunosuppressants are the current mainstay of therapy but carry risks for patients with bullous pemphigoid. Read this article to find out more

Pathophysiology of Bullous Pemphigoid

Pathophysiology of Bullous Pemphigoid

In bullous pemphigoid, autoimmunity to BP180 and BP230 is thought to trigger a type 2 inflammatory response. Read this article to find out more

Patient morbidity and mortality in BP

Patient morbidity and mortality in BP

Many factors, including older age and multimorbidity, are associated with mortality in bullous pemphigoid. Read this article to find out more

Inspiration and innovation

Get inspired and stay at the forefront of innovation with the following resources

Prevalence of Asthma

Asthma

Prevalence of Asthma

Experts recommendations on Late Onset Pompe Disease (LOPD) differential diagnosis from GCC

Rare Diseases

Experts recommendations on Late Onset Pompe Disease (LOPD) differential diagnosis from GCC

Expert group consensus from the Arabian Peninsula on the diagnosis of Late Onset Pompe Disease (LOPD)

Rare Diseases

Expert group consensus from the Arabian Peninsula on the diagnosis of Late Onset Pompe Disease (LOPD)

Expert group consensus from the Arabian Peninsula on the diagnosis of Late Onset Pompe Disease for Orthopedists

Rare Diseases

Expert group consensus from the Arabian Peninsula on the diagnosis of Late Onset Pompe Disease for Orthopedists

Differential diagnosis of Late Onset Pompe Disease (LOPD) and myotonic dystrophy type 1 through abdominal ultrasonography

Rare Diseases

Differential diagnosis of Late Onset Pompe Disease (LOPD) and myotonic dystrophy type 1 through abdominal ultrasonography

The InRange Study

Diabetes

The InRange Study

Edition Junior Study - Helping patients with type 1 diabetes (T1D) to find better treatment options

Diabetes

Edition Junior Study - Helping patients with type 1 diabetes (T1D) to find better treatment options

Prevalence of LOPD in patients with undifferentiated proximal myopathy and undiagnosed muscle biopsy

Rare Diseases

Prevalence of LOPD in patients with undifferentiated proximal myopathy and undiagnosed muscle biopsy

Events

Stay up to date and register for the latest events and view webinar recordings

Dia-Tour: Navigating New Destinations in Diabetes Management

Dia-Tour: Navigating New Destinations in Diabetes Management

Fabry Monitoring Matters Webinar Series

Fabry Monitoring Matters Webinar Series

World Diabetes Day

World Diabetes Day

Safe & Smart - Dr. Salah

Safe & Smart - Dr. Salah

Safe & Smart - Dr. Nabil

Safe & Smart - Dr. Nabil

Safe & Smart - Dr. Khudhair

Safe & Smart - Dr. Khudhair

Safe & Smart - Dr. Kalra

Safe & Smart - Dr. Kalra

Hypertension and CVD

Hypertension and CVD

Dr. Hany talks about the Focus on BP to Reduce CVD Risks.